Lamotrigine for Absence Seizures
The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1999-08-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/2034 |
Similar Items
-
Occurrence of hyperventilation-induced high amplitude rhythmic slowing with altered awareness after successful treatment of typical absence seizures and a network hypothesis
by: Simone Mattozzi, et al.
Published: (2021-01-01) -
Prognosis of Early Onset Absence Epilepsy
by: J Gordon Millichap
Published: (2013-11-01) -
Absence Epilepsy and Moyamoya Disease
by: J Gordon Millichap
Published: (2006-04-01) -
Rett Syndrome, Seizures and Non-Seizures
by: J Gordon Millichap
Published: (1998-03-01) -
Seizures During Exercise
by: J Gordon Millichap
Published: (1988-04-01)